Janux Therapeutics, Inc. JANX
11.38 USD -0.12 (-1.04%)
Nov 13, 2026, 12:28 PM EST
11.16 Day range 11.49
11.16 52-week range 35.34
- YTD
- -17.57%
- 1 year
- -58.58%
JANX revenue history
Revenue is income from the company’s ordinary business activities.
10,000,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 10,000,000 | -588,000 | -5.55% |
| FY 2024 | 2024-12-31 | 10,588,000 | 2,505,000 | 30.99% |
| FY 2023 | 2023-12-31 | 8,083,000 | -529,000 | -6.14% |
| FY 2022 | 2022-12-31 | 8,612,000 | 4,975,000 | 136.79% |
| FY 2021 | 2021-12-31 | 3,637,000 | 3,637,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:09.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.